Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on July 31, 2003; DOI 10.1182/blood-2003-04-1075.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-04-1075v1
102/10/3719    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michallet, M.-C.
Right arrow Articles by Genestier, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michallet, M.-C.
Right arrow Articles by Genestier, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted April 7, 2003
Accepted July 21, 2003

Cathepsin B-dependent apoptosis triggered by antithymocyte globulins (ATGs): a novel mechanism of T cell depletion

Marie-Cecile Michallet, Frederic Saltel, Xavier Preville, Monique Flacher, Jean-Pierre Revillard, and Laurent Genestier*

Laboratoire d'Immunopharmacologie, INSERM, Unite 503, Centre d'Etudes et de Recherche en Virologie et Immunologie, Lyon, France
Laboratoire de Biologie Moléculaire et Cellulaire, UMR 5665 CNRS/ENS, Lyon, France
BT PHARMA-BIOTOP, Institut Pasteur, Paris, France
Laboratoire d'Immunopharmacologie, INSERM, Unite 503, Centre d'Etudes et de Recherche en Virologie et Immunologie, Lyon, France; Centre d'Etudes et de Recherche en Virologie et Immunologie, INSERM, Unite 404, Lyon, France

* Corresponding author; email: genestier{at}cervi-lyon.inserm.fr.

Antithymocyte globulins (ATGs), the IgG fraction of sera from rabbits or horses immunized with human thymocytes or T cell lines, are used in conditioning regimens for bone marrow transplantation, treatment of acute graft-versus-host disease, prevention or treatment of acute rejection in organ transplantation and in severe bone marrow aplasia. In nonhuman primates, ATGs induce a rapid, dose-dependent, T cell depletion in peripheral lymphoid tissues, where apoptotic cells can be demonstrated in T cell zones. We show here that increasing ATG concentrations in vitro resulted in a reduction of lymphocyte proliferative responses, associated with a rapid increase in the percentage of apoptotic cells. Apoptosis did not require prior exposure to interleukin-2, nor was it the consequence of CD178/CD95 or TNF/TNF-R interactions, and was therefore clearly different from activation-induced cell death. Cytochrome c release, caspase-9 and caspase-3 activation were not implicated, excluding a direct involvement of the intrinsic mitochondrial pathway. The cystein protease inhibitor E64d, as well as cathepsin B specific inhibitors, conferred significant protection, while apoptosis was associated with the release of active cathepsin B into the cytosol. The data demonstrate a role for cathepsin B in T cell apoptosis induced by ATGs at concentrations achieved during clinical use.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
G. Simon, M. Parker, V. Ramiya, C. Wasserfall, Y. Huang, D. Bresson, R. F. Schwartz, M. Campbell-Thompson, L. Tenace, T. Brusko, et al.
Murine Antithymocyte Globulin Therapy Alters Disease Progression in NOD Mice by a Time-Dependent Induction of Immunoregulation
Diabetes, February 1, 2008; 57(2): 405 - 414.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Loh, Y. Oyama, L. Statkute, K. Quigley, K. Yaung, E. Gonda, W. Barr, B. Jovanovic, R. Craig, D. Stefoski, et al.
Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used
Blood, March 15, 2007; 109(6): 2643 - 2548.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
U. Maitra, J. Seo, M. M. Lozano, and J. P. Dudley
Differentiation-Induced Cleavage of Cutl1/CDP Generates a Novel Dominant-Negative Isoform That Regulates Mammary Gene Expression
Mol. Cell. Biol., October 15, 2006; 26(20): 7466 - 7478.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Wang, N. Muller, K. G. McPherson, and H. M. Reichardt
Glucocorticoids Engage Different Signal Transduction Pathways to Induce Apoptosis in Thymocytes and Mature T Cells
J. Immunol., February 1, 2006; 176(3): 1695 - 1702.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
J. He, Y. Tohyama, K.-i. Yamamoto, M. Kobayashi, Y. Shi, T. Takano, C. Noda, K. Tohyama, and H. Yamamura
Lysosome is a primary organelle in B cell receptor-mediated apoptosis: an indispensable role of Syk in lysosomal function
Genes Cells, January 1, 2005; 10(1): 23 - 35.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020